科研之友
微信
新浪微博
Facebook
分享链接
摘要
This perspective is part of an annual series of papers discussing drugs dropped from development in the previous year. Specifically, this paper focuses on the 19 cardiovascular drugs discontinued in 2011 after reaching preclinical or Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.
- 出版日期2012-10
- 单位中国药科大学
